Semeia
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $4.5M
Investors
- 3
About Semeia
Based in Paris, France, and founded in 2017, Semeia SAS operates as a software development company. The company was founded by its CEO Pierre Hornus, Mathieu Godart, and President Daniel Szeftel. The product line of Semeia includes Nephro Wise, which is software that monitors the blood pressure and weight of patients; Mind Wise, which is software that monitors patients' mental and somatic health; Onco Wise, which is software that monitors breast cancer patients; Cardio Wise; Pneumo Wise; and Rheumato Wise.
Who invested in Semeia
3 investors across 1 round
See all investors in Semeia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 22, 2022
Amount
$4.5M
Investors
Questions about Semeia
Who invested in Semeia?
Semeia has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Semeia raised?
Semeia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Semeia last raise money?
Semeia's most recent round on record is a Series A, in Nov 2022.
What does Semeia do?
Based in Paris, France, and founded in 2017, Semeia SAS operates as a software development company.
Where is Semeia headquartered?
Semeia is headquartered in Paris, France.
Which VCs invest in companies like Semeia?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Balderton Capital back software companies at Semeia's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Semeia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.